|
GDAP2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89596999999875E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.194000E-04 |
| Normal-vs-Stage2 |
3.199400E-04 |
| Normal-vs-Stage3 |
1.95325999999829E-05 |
| Normal-vs-Stage4 |
4.35770000000169E-05 |
| Stage1-vs-Stage2 |
3.053200E-01 |
| Stage1-vs-Stage3 |
7.923600E-02 |
| Stage1-vs-Stage4 |
1.313830E-01 |
| Stage2-vs-Stage3 |
7.896400E-01 |
| Stage2-vs-Stage4 |
7.059600E-01 |
| Stage3-vs-Stage4 |
8.933800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.86439999999766E-05 |
| Normal-vs-AfricanAmerican |
2.584200E-02 |
| Normal-vs-Asian |
3.824900E-04 |
| Caucasian-vs-AfricanAmerican |
5.808400E-01 |
| Caucasian-vs-Asian |
6.855400E-01 |
| AfricanAmerican-vs-Asian |
4.187800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.40380000005036E-06 |
| Normal-vs-Female |
1.020560E-04 |
| Male-vs-Female |
1.154800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.981000E-03 |
| Normal-vs-Age(41-60Yrs) |
3.74110000000982E-06 |
| Normal-vs-Age(61-80Yrs) |
1.97927999999736E-05 |
| Normal-vs-Age(81-100Yrs) |
2.206400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.084100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.188400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.135000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.009200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.014000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.322000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.262600E-01 |
| Classical-VS-Follicular |
1.656950E-01 |
| Classical-VS-Other |
8.232200E-01 |
| Classical-VS-Normal |
2.551800E-04 |
| Tall-VS-Follicular |
8.933000E-01 |
| Tall-VS-Other |
8.431200E-01 |
| Tall-VS-Normal |
1.402420E-03 |
| Follicular-VS-Other |
8.270000E-01 |
| Follicular-VS-Normal |
1.989460E-04 |
| Other-VS-Normal |
1.032950E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.68670000003191E-06 |
| Normal-vs-N1 |
1.594640E-04 |
| N0-vs-N1 |
5.946800E-01 |
|
|
